Evanson Asset Management’s MediciNova MNOV Stock Holding History

Evanson Asset Management’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-15,000	Closed	-$112K	–	221
2016 Q3	$112K	Hold	15,000	–	–	0.03%	196
2016 Q2	$113K	Hold	15,000	–	–	0.03%	194
2016 Q1	$110K	Buy	+15,000	New	+$74.3K	0.04%	189

Other funds holding MNOV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Evanson Asset Management's MNOV Position: Q4 2016 in Review

Evanson Asset Management sold out of MediciNova (MNOV) in Q4 2016, closing a stake of 15,000 shares — an estimated $112K sold.

Evanson Asset Management first reported a position in MNOV in Q1 2016 and held it in 3 quarters. The position peaked at $113K in Q2 2016. 53 funds tracked by Wall St. Rank hold MNOV as of Q4 2016.

Evanson Asset Management reported no remaining MediciNova position as of Q4 2016 after selling out during the quarter.
Evanson Asset Management sold 15,000 MediciNova shares in Q4 2016, an estimated $112K.
Evanson Asset Management first reported a position in MediciNova in Q1 2016 and held it in 3 quarters.
Evanson Asset Management's MediciNova position peaked at $113K in Q2 2016.
53 funds tracked by Wall St. Rank held MediciNova as of Q4 2016.

Based on Evanson Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.